Compounds > olmesartan

Page last updated: 2024-09-04

olmesartan and tak 491

olmesartan has been researched along with tak 491 in 8 studies

Compound Research Comparison

Studies (olmesartan)	Trials (olmesartan)	Recent Studies (post-2010) (olmesartan)	Studies (tak 491)	Trials (tak 491)	Recent Studies (post-2010) (tak 491)
841	185	554	78	25	74

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	8 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bakris, GL; Cao, C; Kupfer, S; Perez, A; Roberts, A; Sica, D; Weber, M; White, WB	1
Bakris, GL; Cao, C; Kupfer, S; Perez, A; Sica, D; Weber, MA; White, WB	1
Bakris, GL; Cushman, WC; Kupfer, S; Lloyd, E; Roberts, A; Sica, D; Weber, MA; White, WB	2
Bakris, GL; Cuadra, RH; Kupfer, S; Lloyd, E; White, WB	1
Cao, C; Perez, A	1
van der Merwe, WM	1
Bakris, GL; Cushman, WC; Ferdinand, KC; Lloyd, E; Weber, MA; White, WB; Wu, J	1

Trials

7 trial(s) available for olmesartan and tak 491

Article	Year
The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure. Journal of clinical hypertension (Greenwich, Conn.), 2011, Volume: 13, Issue:2 Topics: Aged; Angiotensin Receptor Antagonists; Argentina; Benzimidazoles; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Mexico; Middle Aged; Oxadiazoles; Peru; Racial Groups; Tetrazoles; Treatment Outcome; United States	2011
Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hypertension (Dallas, Tex. : 1979), 2011, Volume: 57, Issue:3 Topics: Adult; Aged; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Oxadiazoles; Tetrazoles; Treatment Outcome; Valine; Valsartan	2011
Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension. Hypertension (Dallas, Tex. : 1979), 2012, Volume: 60, Issue:2 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Black People; Blood Pressure; Chlorthalidone; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Oxadiazoles; Severity of Illness Index; Tetrazoles; Treatment Outcome; White People	2012
Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes. Journal of hypertension, 2016, Volume: 34, Issue:4 Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Imidazoles; Male; Middle Aged; Oxadiazoles; Prediabetic State; Tetrazoles; Valsartan	2016
The Impact of Azilsartan Medoxomil Treatment (Capsule Formulation) at Doses Ranging From 10 to 80 mg: Significant, Rapid Reductions in Clinic Diastolic and Systolic Blood Pressure. Journal of clinical hypertension (Greenwich, Conn.), 2017, Volume: 19, Issue:3 Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Oxadiazoles; Tetrazoles; Treatment Outcome	2017
A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension. Journal of hypertension, 2018, Volume: 36, Issue:4 Topics: Aged; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Chlorthalidone; Diuretics; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Oxadiazoles; Tetrazoles	2018
Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic Hypertension. The American journal of cardiology, 2018, 11-01, Volume: 122, Issue:9 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Black or African American; Chlorthalidone; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Oxadiazoles; Tetrazoles; United States; White People	2018

Other Studies

1 other study(ies) available for olmesartan and tak 491

Article	Year
Treatment of hypertension in CKD patients with azilsartan/chlorthalidone vs olmesartan/hydrochlorothiazide. Journal of clinical hypertension (Greenwich, Conn.), 2018, Volume: 20, Issue:4 Topics: Antihypertensive Agents; Benzimidazoles; Chlorthalidone; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Oxadiazoles; Renal Insufficiency, Chronic; Tetrazoles	2018